Both in Pharmaceuticals
Azora Therapeutics vs Moleculin Biotech
| Metric | AZR | MBRX |
|---|---|---|
| Price | $3.71 | $8.73 |
| Market cap | $9.7M | $8.9M |
| Today | −8.40% | +3.19% |
| 1 month | — | −0.5% |
| 6 months | — | −82.5% |
| Year to date | — | −86.8% |
| 1 year | — | −96.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 850.1% |
| Short % of float | — | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).